Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
0.6067
+0.0322 (5.60%)
At close: Mar 31, 2026, 4:00 PM EDT
0.6199
+0.0132 (2.18%)
After-hours: Mar 31, 2026, 7:58 PM EDT
Humacyte Market Cap
Humacyte has a market cap or net worth of $134.7 million as of March 31, 2026. Its market cap has decreased by -65.22% in one year.
Market Cap
134.70M
Enterprise Value
149.55M
1-Year Change
-65.22%
Ranking
Category
Stock Price
$0.61
Market Cap Chart
Since December 1, 2020, Humacyte's market cap has increased from $124.31M to $134.70M, an increase of 8.36%. That is a compound annual growth rate of 1.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2026 | 134.70M | -27.34% |
| Dec 31, 2025 | 185.37M | -71.47% |
| Dec 31, 2024 | 649.78M | 120.90% |
| Dec 29, 2023 | 294.15M | 35.19% |
| Dec 30, 2022 | 217.58M | -70.86% |
| Dec 31, 2021 | 746.77M | 471.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 1, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immunic | 144.82M |
| Precision BioSciences | 142.43M |
| Unicycive Therapeutics | 141.41M |
| NeOnc Technologies Holdings | 140.31M |
| Fate Therapeutics | 139.52M |
| Oramed Pharmaceuticals | 136.12M |
| Spero Therapeutics | 135.47M |
| Kalaris Therapeutics | 132.30M |